NewsLSE Cannabis Debutant Company MGC Pharma Set ‘To Break...

LSE Cannabis Debutant Company MGC Pharma Set ‘To Break Even This Year’

-

THE London Stock Exchange’s medical cannabis debutant MGC Pharmaceuticals has released is first quarterly update since listing showing record revenues of almost £500,000.

In the market update for the quarter up to March 31, it announced it has signed a supply deal to provide nutraceuticals producer and distributor Swiss PharmaCan a minimum of 40,000 units, per quarter, of its Covid-19 alleviating drug ArtemiC.

It reported progress on a number of trial initiatives including the launch of an in-vitro study into the treatment of aggressive glioblastoma brain cancer.

Roby Zomer, CEO of MGC Pharma, said: “This has been an historic quarter for MGC Pharma, following our listing on LSE, along with record sales for our proprietary pharmaceutical products. 

“MGC Pharma is well positioned for the future, with clinical trials for CannEpil and CogniCann due to begin in the coming quarter, alongside phase III clinical trials for CimetrA, which have the potential to treat the many people suffering as a result of Covid-19.

“MGC Pharma is now in an excellent position to realise its potential and build on the foundations that have been set in the past 12 months, as we remain on target to reach break even this financial year.”

MGC Pharma is dual-listed on both the Australian Securities Exchange and the LSE and valued at around £80m.


Peter
Peter McCusker is an experienced news and business editor, who believes it’s time to fully embrace the multiple, proven, medical benefits of the cannabis plant.

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Latest news

New French Hemp Rules Under-fire Over Proposals To Outlaw CBD Flowers

THE French government is pressing ahead with moves to outlaw the sale of CBD flowers despite recent decisions to...

UK CBD Brand OTO Signs Deal With Synthetic CBD Brand Pureform Global

LONDON-based wellness and CBD brand, OTO, have signed a partnership deal with Pureform Global. This groundbreaking partnership will enable...

Significant Year-On-Year Rise In German Medical Cannabis Flower Imports

DESPITE a decline in cannabis flower imports for the first quarter of 2021 the German medical cannabis market continues...

Low-Cost Medical Cannabis Flowers To Be Exported From Colombia For The First Time

COLOMBIA is set to permit the export of medical cannabis flower for the first time in what could be...

UK Cannabis Business Eco Equity Announces 100% Equity Acquisition By US Firm Virtual Medical International

ECO Equity Limited a UK company with cultivation assets in Africa, will combine its operations with Virtual Medical International...

New Amendments Could Delay Passing Of Greek Medical Cannabis Bill Until Next Year

GREEK businesses are preparing for amendments to the Mediterranean country’s cannabis laws allowing the cultivation, sale and export of...

Must read

New French Hemp Rules Under-fire Over Proposals To Outlaw CBD Flowers

THE French government is pressing ahead with moves to...

Low-Cost Medical Cannabis Flowers To Be Exported From Colombia For The First Time

COLOMBIA is set to permit the export of medical...

You might also likeRELATED
Recommended to you